Dr. Ewa Moric-Janiszewska, PhD, was awarded the doctoral degree in medical sciences on July 12, 2001. The degree was conferred by the Silesian Medical Academy (currently the Medical University of Silesia in Katowice, Poland). Doctoral Dissertation Details Thesis Title: „Nowe mutacje eksonu 21 genu kodującego beta-miozynę sercową u chorych z rodzinną kardiomiopatią przerostową” (Novel mutations of exon 21 of the gene encoding cardiac beta-myosin in patients with familial hypertrophic cardiomyopathy) Academic Career and Research Focus Following her doctoral defense, Dr. Ewa Moric-Janiszewska continued her academic career at the Faculty of Pharmaceutical Sciences in Sosnowiec, operating under the Medical University of Silesia in Katowice. She currently holds the position of Assistant Professor (Adiunkt) in the Department of Biochemistry. Her research extends the work initiated during her PhD, focusing extensively on molecular cardiology, genetic predispositions to heart diseases in children and adolescents, and novel biochemical markers of circulatory failure. Her primary research areas include: Molecular aspects of arrhythmogenic heart diseases. The evaluation of Galectin-3 and Serum NT-proBNP as markers for myocardial dysfunction. Genetic diagnostics and gene polymorphism in Long QT Syndrome (LQTS). Dr. Moric-Janiszewska frequently publishes her findings in peer-reviewed medical journals and actively serves as a thesis advisor and reviewer within her university department